R1 Therapeutics News and Activities

Acquisition, funding and merger involving R1 Therapeutics.

• R1 Therapeutics has just announced a $78 Million fundraising (posted on March 26 2026).

View the org chart displaying its 12 main executives

Most searched biographies at R1 Therapeutics

• Krishna Polu, Chief Executive Officer
• Steven Landau, Director
• Ben Auspitz, Director

Create your alert
to follow the executive moves at R1 Therapeutics.

R1 Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by R1 Therapeutics

Social media about R1 Therapeutics

• R1 Therapeutics on Wikipedia, Google News & Yahoo Finance
• R1 Therapeutics on LinkedIn, X (Twitter) & YouTube